News & Events

• November 10, 2021
  

  C-Path Promotes Nick King and Emily Turner to Executive Directors

  Critical Path Institute (C-Path) today announced it has promoted Nicholas King, M.S., as Executive Director of its Predictive Safety Testing Consortium (PSTC) and Emily Turner, Ph.D., as Executive Director of the Huntington’s Disease Regulatory Science Consortium (HD-RSC).

• November 9, 2021
  

  C-Path and Cure Mito Announce Data Sharing Agreement to Support Treatment Development For Leigh Syndrome and Mitochondrial Disease

  Critical Path Institute (C-Path) and Cure Mito Foundation (Cure Mito) today announced a joint collaboration to significantly promote data sharing and accelerate Leigh syndrome and other rare mitochondrial disease data incorporation into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).

• November 9, 2021
  

  C-Path Joins New Coalition to Improve Patient Care and Address Unmet Medical Needs through Community-Level Clinical Trials

  WASHINGTON and TUCSON, Ariz., November 9, 2021 — Launching today, the Advancing Clinical Trials at the Point of Care (ACT@POC) Coalition will generate quality clinical research evidence in real time to better evaluate treatments and therapeutics, including those to treat COVID-19. The Coalition will engage a broader, more diverse group of patients and providers and develop digital health tools that make clinical trials simpler to run and more accessible to patients.

• November 1, 2021
  

  C-Path’s Quantitative Medicine Team to Lead Trainee Tutorial at American Conference on Pharmacometrics

  On November 12, 2021 Jagdeep Podichetty, Director of Predictive Analytics within Quantitative Medicine program at Critical Path Institute (C-Path) will chair a trainee tutorial at the American Conference on Pharmacometrics (ACoP). The trainee tutorial titled Application of Machine Learning in Drug Development with Regulatory Considerations will expose trainees to various drug development case studies that...
• October 14, 2021
  

  Academic Innovation Leader and Experienced Scientist to Join C-Path’s PKD Consortium

  C-Path today announced it has named Sorin Fedeles, Ph.D., MBA as Executive Director of its Polycystic Kidney Disease Outcomes Consortium (PKDOC), effective October 1, 2021.